Better Therapeutics Inc
Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease… Read more
Better Therapeutics Inc (BTTX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.598x
Based on the latest financial reports, Better Therapeutics Inc (BTTX) has a cash flow conversion efficiency ratio of 0.598x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.94 Million) by net assets ($-9.94 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Better Therapeutics Inc - Cash Flow Conversion Efficiency Trend (2019–2022)
This chart illustrates how Better Therapeutics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Better Therapeutics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Better Therapeutics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Leiner Pak Gelatine Ltd
KAR:LPGL
|
N/A |
|
Adamjee Insurance Company Ltd
KAR:AICL
|
-0.002x |
|
Asia Pacific Securities JSC
VN:APS
|
N/A |
|
SFS REAL ESTATE INVESTMENT TRUST
XNSA:SFSREIT
|
N/A |
|
Arma Services Inc
PINK:ARMV
|
0.001x |
|
Viet Tien Son Real Estate Holding Co
VN:AAV
|
N/A |
|
TDT Investment and Development JSC
VN:TDT
|
N/A |
|
Janana De Malucho Textile Mills Ltd
KAR:JDMT
|
N/A |
Annual Cash Flow Conversion Efficiency for Better Therapeutics Inc (2019–2022)
The table below shows the annual cash flow conversion efficiency of Better Therapeutics Inc from 2019 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $-899.00K | $-28.93 Million | 32.180x | +3934.31% |
| 2021-12-31 | $36.72 Million | $-30.82 Million | -0.839x | -198.23% |
| 2020-12-31 | $-6.76 Million | $-5.77 Million | 0.854x | -91.69% |
| 2019-12-31 | $-605.00K | $-6.22 Million | 10.276x | -- |